Clinical standards for the dosing and management of TB drugs

Autor: Alffenaar, J W C, Stocker, S L, Forsman, L Davies, Garcia-Prats, A, Heysell, S K, Aarnoutse, R E, Akkerman, O W, Aleksa, A, van Altena, R, de Oñata, W Arrazola, Bhavani, P K, Van't Boveneind-Vrubleuskaya, N, Carvalho, A C C, Centis, R, Chakaya, J M, Cirillo, D M, Cho, J G, D Ambrosio, L, Dalcolmo, M P, Denti, P, Dheda, K, Fox, G J, Hesseling, A C, Kim, H Y, Köser, C U, Marais, B J, Margineanu, I, Märtson, A G, Torrico, M Munoz, Nataprawira, H M, Ong, C W M, Otto-Knapp, R, Peloquin, C A, Silva, D R, Ruslami, R, Santoso, P, Savic, R M, Singla, R, Svensson, E M, Skrahina, A, van Soolingen, D, Srivastava, S, Tadolini, M, Tiberi, S, Thomas, T A, Udwadia, Z F, Vu, D H, Zhang, W, Mpagama, S G, Schön, T, Migliori, G B

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol 26, iss 6
International Journal of Tuberculosis and Lung Disease, 26, 6, pp. 483-499
International Journal of Tuberculosis and Lung Disease, 26, 483-499
International Journal of Tuberculosis and Lung Disease, 26(6), 483-499. International Union against Tubercul. and Lung Dis.

BACKGROUND: Optimal drug dosing is important to ensure adequate response to treatment, prevent development of drug resistance and reduce drug toxicity. The aim of these clinical standards is to provide guidance on ‘best practice´ for dosing and ma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aef5c7cecf38f14102fd039dc3e030b
https://escholarship.org/uc/item/59969461

Population pharmacokinetics and limited sampling strategy for first-line tuberculosis drugs and moxifloxacin

Autor: Magis-Escurra, C., Later-Nijland, H.M.J., Alffenaar, J.W.C., Broeders, J., Burger, D.M., van Crevel, R., Boeree, M.J., Donders, A.R.T., van Altena, R., van der Werf, T.S., Aarnoutse, R.E.

Publikováno v: In International Journal of Antimicrobial Agents September 2014 44(3):229-234

Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

Autor: Bastos, Mayara L., Hussain, Hamidah, Weyer, Karin, Garcia-Garcia, Lourdes, Leimane, Vaira, Leung, Chi Chiu, Narita, Masahiro, Penã, Jose M., Ponce-de-Leon, Alfredo, Seung, Kwonjune J., Shean, Karen, Sifuentes-Osornio, José, Van der Walt, Martie, Van der Werf, Tjip S., Yew, Wing Wai, Menzies, Dick, Ahuja, S., Ashkin, D., Avendaño, M., Banerjee, R., Bauer, M., Becerra, M., Benedetti, A., Burgos, M., Centis, R., Chan, E.D., Chiang, C.Y., Cobelens, F., Cox, H., D'Ambrosio, L., de Lange, W.C.M., DeRiemer, K., Enarson, D., Falzon, D., Flanagan, K., Flood, J., Gandhi, N., Garcia-Garcia, L., Granich, R.M., Hollm-Delgado, M.G., Holtz, T.H., Hopewell, P., Iseman, M., Jarlsberg, L.G., Keshavjee, S., Kim, H.R., Koh, W.J., Lancaster, J., Lange, C., Leimane, V., Leung, C.C., Li, J., Menzies, D., Migliori, G.B., Mitnick, C.M., Narita, M., Nathanson, E., Odendaal, R., O'Riordan, P., Pai, M., Palmero, D., Park, S.K., Pasvol, G., Pena, J., Pérez-Guzmán, C., Ponce-de-Leon, A., Quelapio, M.I.D., Quy, H.T., Riekstina, V., Robert, J., Royce, S., Salim, M., Schaaf, H.S., Seung, K.J., Shah, L., Shean, K., Shim, T.S., Shin, S.S., Shiraishi, Y., Sifuentes-Osornio, J., Sotgiu, G., Strand, M.J., Sung, S.W., Tabarsi, P., Tupasi, T.E., Vargas, M.H., van Altena, R., van der Walt, M., van der Werf, T.S., Viiklepp, P., Westenhouse, J., Yew, W.W., Yim, J.J.

The clinical validity of drug susceptibility testing (DST) for pyrazinamide, ethambutol, and second-line antituberculosis drugs is uncertain. In an individual patient data meta-analysis of 8955 patients with confirmed multidrug-resistant tuberculosis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______805::d8be697a15c2d159a159c04bd039ad49
http://doc.rero.ch/record/296190/files/ciu619.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.